Stock listing

INVA Stock Price, News, Filings & Events — Innoviva, Inc.

Selected listing: INVA · NASDAQ · USD · US

This page tracks Innoviva, Inc.'s INVA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following INVA:NASDAQ. INVA:NASDAQ is the stock-level entry point for investors researching Innoviva, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Innoviva, Inc. is a public company traded under the ticker INVA in the American market. The company has a market capitalization of approximately $1.6 billion. Innoviva focuses on developing and commercializing innovative therapies to address unmet medical needs.

INVA:NASDAQUSDUSUpdated September 11, 2026
Innoviva, Inc. logo
Ticker
INVA:NASDAQ
Asset type
Stock
Market cap
$1.49B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD

Innoviva, Inc. INVA:NASDAQ stock context

This page tracks Innoviva, Inc.'s INVA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following INVA:NASDAQ. INVA:NASDAQ is the stock-level entry point for investors researching Innoviva, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Innoviva, Inc. is a public company traded under the ticker INVA in the American market. The company has a market capitalization of approximately $1.6 billion. Innoviva focuses on developing and commercializing innovative therapies to address unmet medical needs.

Latest news from Innoviva, Inc.

All Innoviva, Inc. news →

Research Innoviva, Inc.

Alternate listings